Merck’s Patent Loss to Gilead May Have Big Impact on Drugmakers
October 31, 2019
Valerie Bauman
Bloomberg Law
Axinn partner Chad Landmon was quoted in the Bloomberg Law article, "Merck’s Patent Loss to Gilead May Have Big Impact on Drugmakers."
Click here to access the article.